MAS1L and renal fibrosis: In the present study, we assumed that RDN could directly inhibit cardio-renal fibrosis through rebalancing RAAS (ACE/Ang II/AT1R & ACE2/Ang-(1-7)/Mas-R) and decreasing SNS activity.